Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)
Inogen (INGN) reported Non-Current Deferred Tax Liability of $6.6 million for Q1 2026, down 11.3% year-over-year from $7.4 million in Q1 2025, and down 2.62% on a QoQ basis from $6.7 million in Q4 2025.
Inogen (INGN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $6.6 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 11.3% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (down 11.3% YoY) and the FY2025 annual result came in at $6.7 million, down 2.86% from the prior year.
- Non-Current Deferred Tax Liability retreated to $6.6 million in Q1 2026 per INGN's latest filing, from $6.7 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $14.0 million in Q4 2022 and bottomed at $6.6 million in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $8.0 million (2024), against an average of $8.3 million.
- The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability plunged 38.79%; it then decreased 0.44% in 2024.
- Tracing INGN's Non-Current Deferred Tax Liability over 5 years: stood at $14.0 million in 2022, then tumbled by 38.79% to $8.5 million in 2023, then fell by 18.63% to $6.9 million in 2024, then decreased by 2.86% to $6.7 million in 2025, then decreased by 2.62% to $6.6 million in 2026.
- Per Business Quant, the three latest INGN Non-Current Deferred Tax Liability figures stand at $6.6 million (Q1 2026), $6.7 million (Q4 2025), and $7.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.57 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2023 | 8.42 Mn |
| Sep 30, 2023 | 8.42 Mn |
| Dec 31, 2022 | 13.95 Mn |
| Dec 31, 2022 | 13.95 Mn |
| Sep 30, 2021 | 24,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 91,000.00 |
| Sep 30, 2020 | 91,000.00 |
| Mar 31, 2020 | 85,000.00 |
| Mar 31, 2020 | 85,000.00 |
| Dec 31, 2019 | 87,000.00 |
| Dec 31, 2019 | 87,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 230,000.00 |
| Jun 30, 2019 | 230,000.00 |
| Mar 31, 2019 | 227,000.00 |
| Mar 31, 2019 | 227,000.00 |
| Dec 31, 2018 | 232,000.00 |
| Dec 31, 2018 | 232,000.00 |
| Sep 30, 2018 | 338,000.00 |
| Sep 30, 2018 | 338,000.00 |
| Jun 30, 2018 | 340,000.00 |
| Jun 30, 2018 | 340,000.00 |
| Mar 31, 2018 | 358,000.00 |
| Mar 31, 2018 | 358,000.00 |
| Dec 31, 2017 | 348,000.00 |
| Dec 31, 2017 | 348,000.00 |
| Sep 30, 2017 | 414,000.00 |
| Sep 30, 2017 | 414,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 400,000.00 |